कृपया अन्य खोज का प्रयास करें
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Ruedi Aebersold | - | - | Member of Scientific Advisory Board |
Lee H. Hartwell | - | - | Member of Scientific Advisory Board |
Melissa B. Epperly | 43 | 2021 | Independent Director |
Farzad Nazem | 59 | 2021 | Independent Director |
Joshua LaBaer | - | - | Member of Scientific Advisory Board |
Matthew McIlwain | 56 | 2021 | Independent Director |
Michael Seth Altman | 39 | 2021 | Independent Director |
Matthew L. Posard | 54 | 2021 | Independent Chairman of the Board |
Emma Lundberg | - | 2021 | Member of Scientific Advisory Board |
Vijay Satyanand Pande | 50 | 2021 | Independent Director |
Sujal M. Patel | 47 | 2021 | Co-Founder, CEO, President, Secretary & Director |
Parag Mallick | 44 | 2021 | Co-Founder, Chief Scientist & Director |
Karen Akinsanya | 54 | 2022 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है